Source: International Congress 2019 – NELSON: the Trafalgar of lung cancer screening?



Rating:

Share or cite this content

Citations should be made in the following way:
D. Baldwin (Nottingham (Nottinghamshire), United Kingdom). How do we handle nodules to minimise the false positive rate?. International Congress 2019 – NELSON: the Trafalgar of lung cancer screening?

Member's Comments

No comment yet.

Related content which might interest you: Residual DNA of Mtb from the bronchoscope channel as a possible cause of false positive results in the diagnosis of tuberculosis Source: Virtual Congress 2021 – Advances in the diagnosis of tuberculosis, multidrug-resistant tuberculosis and nontuberculous mycobacterial disease Year: 2021 IFN γ tests for tuberculosis – false positives with other T cell disease processes? Source: Annual Congress 2008 - Interferon-gamma methods for the diagnosis of tuberculosis infection and disease Year: 2008 Smoking is a strong independent risk factor for indeterminate and false negative IGRA results Source: Annual Congress 2011 - What is new in tuberculosis immunodiagnosis? Year: 2011 28 years of newborn screening in the U.K.: false negatives Source: Annual Congress 2009 - Cystic fibrosis: advances in clinical research Year: 2009 Bronchiectasis and false positive cases in a lung cancer screening program Source: Virtual Congress 2020 – Screening and early lung cancer Year: 2020 Hitting the target - How well can the negative predictive value of targeted EBUS be measured? Source: International Congress 2019 – Diagnosis of lung cancer Year: 2019 Is electronic diary alert a false alarm in clinical studies? Source: International Congress 2019 – Innovations in primary care assessment and management Year: 2019 How to deal with the detected nodule ? Source: International Congress 2016 – Should we start screening programmes in Europe? Year: 2016 Difficult-to-wean patients: can we avoid the problem? Source: ERS Skills Course 2016 Year: 2016 A study to assess the magnitude and reasons of initial default among sputum smear positive pulmonary tuberculosis patients Source: Annual Congress 2010 - Tuberculosis control Year: 2010 A low cost, easily implementable method of shortening patient pathways in imaging incidentally suspicious for lung malignancy Source: International Congress 2019 – Imaging for prognostication and disease characterisation: 2019 update Year: 2019 Open and close thoracotomy rate: can the physician contribute? Source: Eur Respir J 2004; 24: Suppl. 48, 75s Year: 2004 Unfavorable factors associated with false negative results of interferon-gamma release assay for tuberculosis Source: Annual Congress 2011 - Risk assessment for tuberculosis Year: 2011 The case of false positive FDG PET/CT scan from foreign body granuloma mimicking malignant disease Source: Eur Respir J 2006; 28: Suppl. 50, 776s Year: 2006 Can we predict who will develop TB among those with a positive interferon-? release assay (IGRA)? Source: International Congress 2018 – Important changes in the management of tuberculosis Year: 2018 Is there any connection between depression and smear positive TB patient's outcome? Source: Eur Respir J 2003; 22: Suppl. 45, 155s Year: 2003 Equivocal diagnoses - handling uncertainty when breaking bad news Source: International Congress 2015 – Deliver bad news Year: 2015 Applying sputum as a diagnostic tool in pneumonia - limited yield, minimal impact on treatment decisions Source: Eur Respir J 2001; 18: Suppl. 33, 502s Year: 2001 CT screening for lung cancer: is it ready for prime time yet or how to enhance pre-test probability? Source: International Congress 2017 – The latest in lung cancer Year: 2017 A conservative approach for subsolid lung nodules: is it safe enough? Source: Eur Respir J 2015; 45: 592-595 Year: 2015